PMGC Holdings Inc

PMGC Holdings Inc(ELAB)の株式分析

$5.090

+0.061 (+1.19%)終値時点

Loading chart…
High
5.358
Open
4.990
VWAP
5.14
Vol
77.86K
Mkt Cap
Low
4.970
Amount
400.15K
EV/EBITDA, TTM
0.00

PMGC Holdings Inc. is a diversified holding company. Its operating companies include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc., ELAB Opportunity Holdings LLC, SVM Machining, Inc., NorthStrive Defense Tech LLC and A&B Aerospace, Inc. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on development and acquisition of aesthetic medicines and therapeutic products. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. Pacific Sun Packaging, Inc. is a specialty packaging provider focused on high-precision, component-level packaging solutions for the electronics and information technology hardware industries. NorthStrive Defense Tech LLC is focused on defense technology, including drone technology, autonomous systems, and next-generation unmanned defense solutions.

AI analysis of PMGC Holdings Inc (ELAB)

sell

Given the current price of 5.31 USD and an RSI of 23.948 indicating oversold conditions, the stock appears to be under significant pressure. However, the 1-year change of -99.53% and a forward P/E of 0 suggest that the company is struggling to generate earnings and is not a viable investment at this time. The main risk is the recent termination of a significant acquisition, which could further hinder growth prospects.

バリュエーション指標

The current forward P/E ratio for PMGC Holdings Inc (ELAB) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
割高
0.00
割安
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
割高
0.00
割安
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
割高
0.00
割安
0.00

Alphio AI Price Scenarios for ELAB

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ELAB

$2.60

シナリオ価格

B

Base

Base · 50%ELAB

$2.11

シナリオ価格

B

Bear

Bear · 25%ELAB

$1.76

シナリオ価格

イベントタイムライン

2026-08-26 (ET)

09:00:00

PMGC Terminates Letter of Intent to Acquire Arizona Company

2026-08-25 (ET)

08:00:00

PMGC Enters Strategic Partnership with Orbit2Orbit

2026-08-21 (ET)

10:00:00

NorthStrive Files New Patents for Muscle Preservation

2026-08-20 (ET)

20:00:00

PMGC Holdings Inc Trading Halted, News Pending

2026-07-06 (ET)

08:00:00

PMGC Merges AGA Precision Systems into A&B Aerospace

ニュース

ELAB FAQ — answered by Alphio AI

PMGC Holdings Inc. is a diversified holding company. Its operating companies include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc., ELAB Opportunity Holdings LLC, SVM Machining, Inc., NorthStrive Defense Tech LLC and A&B Aerospace, Inc. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on development and acquisition of aesthetic medicines and therapeutic products. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. Pacific Sun Packaging, Inc. is a specialty packaging provider focused on high-precision, component-level packaging solutions for the electronics and information technology hardware industries. NorthStrive Defense Tech LLC is focused on defense technology, including drone technology, autonomous systems, and next-generation unmanned defense solutions. It operates in the Basic Materials sector.

Given the current price of 5.31 USD and an RSI of 23.948 indicating oversold conditions, the stock appears to be under significant pressure. However, the 1-year change of -99.53% and a forward P/E of 0 suggest that the company is struggling to generate earnings and is not a viable investment at this time. The main risk is the recent termination of a significant acquisition, which could further hinder growth prospects.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める